Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP

Maria Kyrgiou; Antonio Athanasiou; Marc Arbyn; Sigurd Lax; Maria R Raspollini; Pekka Nieminen; Xavier Carcopino; Jacob Bornstein; Murat Gultekin; Evangelos Paraskevaidis

doi:10.1016/S1470-2045(22)00191-7

Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP

Maria Kyrgiou
, Antonio Athanasiou
, Marc Arbyn
, Sigurd Lax
, Maria R Raspollini
, Pekka Nieminen
, Xavier Carcopino
, Jacob Bornstein
, Murat Gultekin
, Evangelos Paraskevaidis

Klinisches Institut für Pathologie und Molekularpathologie

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	e385-e392
Seitenumfang	23
Fachzeitschrift	The Lancet Oncology
Volume	23
Ausgabenummer	8
DOIs	https://doi.org/10.1016/S1470-2045(22)00191-7
Publikationsstatus	Veröffentlicht - Aug. 2022

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

301101 Allgemeine Pathologie
301108 Molekulare Pathologie

Zugriff auf Dokument

10.1016/S1470-2045(22)00191-7

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Kyrgiou, M., Athanasiou, A., Arbyn, M., Lax, S., Raspollini, M. R., Nieminen, P., Carcopino, X., Bornstein, J., Gultekin, M., & Paraskevaidis, E. (2022). Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP. The Lancet Oncology, 23(8), e385-e392. https://doi.org/10.1016/S1470-2045(22)00191-7

@article{8ff31ccf6bbc427390b90413af5cb015,

title = "Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP",

author = "Maria Kyrgiou and Antonio Athanasiou and Marc Arbyn and Sigurd Lax and Raspollini, \{Maria R\} and Pekka Nieminen and Xavier Carcopino and Jacob Bornstein and Murat Gultekin and Evangelos Paraskevaidis",

year = "2022",

month = aug,

doi = "10.1016/S1470-2045(22)00191-7",

language = "English",

volume = "23",

pages = "e385--e392",

journal = "The Lancet Oncology",

issn = "1474-5488",

number = "8",

}

Kyrgiou, M, Athanasiou, A, Arbyn, M, Lax, S, Raspollini, MR, Nieminen, P, Carcopino, X, Bornstein, J, Gultekin, M & Paraskevaidis, E 2022, 'Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP', The Lancet Oncology, Jg. 23, Nr. 8, S. e385-e392. https://doi.org/10.1016/S1470-2045(22)00191-7

Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP. / Kyrgiou, Maria; Athanasiou, Antonio; Arbyn, Marc et al.
in: The Lancet Oncology, Volume 23, Nr. 8, 08.2022, S. e385-e392.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP

AU - Kyrgiou, Maria

AU - Athanasiou, Antonio

AU - Arbyn, Marc

AU - Lax, Sigurd

AU - Raspollini, Maria R

AU - Nieminen, Pekka

AU - Carcopino, Xavier

AU - Bornstein, Jacob

AU - Gultekin, Murat

AU - Paraskevaidis, Evangelos

PY - 2022/8

Y1 - 2022/8

UR - https://www.scopus.com/pages/publications/85134850748

U2 - 10.1016/S1470-2045(22)00191-7

DO - 10.1016/S1470-2045(22)00191-7

M3 - Article

SN - 1474-5488

VL - 23

SP - e385-e392

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 8

ER -